Unique Ingredient Identifier OP1R32D61U is listed as a ingredient substance
| RN | 9004-34-6 |
| EC | 232-674-9 |
| NCIT | C79876 |
| RXCUI | 1000577 |
| MF | Polymer substance not supported |
UNII OP1R32D61U MICROCRYSTALLINE CELLULOSE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | TABLET, EXTENDED RELEASE | 18.04 MG |
| INTRA-ARTICULAR | INJECTION | 0.05 % |
| INTRAMUSCULAR | INJECTION | 0.05 % |
| INTRAVITREAL | IMPLANT | 1.66 MG |
| NASAL | SPRAY, METERED | 1.5 MG/INH |
| ORAL | CAPSULE | 359 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 139.1 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 44.33 MG |
| ORAL | CAPSULE, COATED PELLETS | 57.03 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 60 MG |
| ORAL | CAPSULE, DELAYED ACTION | 131.6 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 60 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 14 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 306.8 MG |
| ORAL | CAPSULE, GELATIN COATED | 60.15 MG |
| ORAL | CAPSULE, HARD GELATIN | 172.2 MG |
| ORAL | CAPSULE, SOFT GELATIN | 105 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 186 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 282.6 MG |
| ORAL | DISPERSIBLE TABLET | 340 MG |
| ORAL | GRANULE | 81.6 mg |
| ORAL | GRANULE, ENTERIC COATED | 789.6 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 27.39 MG |
| ORAL | GRANULE, FOR RECONSTITUTION | 25 MG |
| ORAL | GRANULE, FOR SUSPENSION | NA |
| ORAL | PELLET | 31.36 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 0.75 MG |
| ORAL | POWDER, FOR RECONSTITUTION | 50 MG/5ML |
| ORAL | POWDER, FOR SUSPENSION | 586.5 MG/1SCP |
| ORAL | SOLUTION | NA |
| ORAL | SUSPENSION | 20 MG/1ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 27.39 MG/206.84 MG |
| ORAL | TABLET | 1553 MG |
| ORAL | TABLET | 165.96 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 182.4 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 665.36 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 10.4 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 639 MG |
| ORAL | TABLET, CHEWABLE | 154.6 MG |
| ORAL | TABLET, COATED | 356 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 152 MG |
| ORAL | TABLET, DELAYED ACTION | 333.25 MG |
| ORAL | TABLET, DELAYED ACTION, COATED | 289.9 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 375.26 MG |
| ORAL | TABLET, DELAYED RELEASE | 736.83 MG |
| ORAL | TABLET, DISPERSIBLE | 155.5 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 391 MG |
| ORAL | TABLET, EXTENDED RELEASE | 675.282 MG |
| ORAL | TABLET, FILM COATED | 563.5 MG |
| ORAL | TABLET, FILM COATED | 294.63 mg |
| ORAL | TABLET, FILM COATED | 140.46 mg |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 328.36 MG |
| ORAL | TABLET, FOR SUSPENSION | 156.25 MG |
| ORAL | TABLET, MULTILAYER, COATED | 34 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 17.3 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 415.92 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 160.24 mg |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 30 MG |
| ORAL | TABLET, SUGAR COATED | 4.64 MG |
| ORAL | TABLET, SUSTAINED ACTION | 363.7 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 100 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 307.52 MG |
| ORAL | TABLET, SUSTAINED RELEASE, FILM COATED | 62.4 MG |
| ORAL | TABLET, UNCOATED, TROCHE | 60 MG |
| SUBLINGUAL | TABLET | 43.2 MG |
| VAGINAL | TABLET | 390 MG |